Correlation Between Advanced Biomedical and Arch Biopartners

Can any of the company-specific risk be diversified away by investing in both Advanced Biomedical and Arch Biopartners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Advanced Biomedical and Arch Biopartners into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Advanced Biomedical Technologies and Arch Biopartners, you can compare the effects of market volatilities on Advanced Biomedical and Arch Biopartners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Advanced Biomedical with a short position of Arch Biopartners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Advanced Biomedical and Arch Biopartners.

Diversification Opportunities for Advanced Biomedical and Arch Biopartners

0.32

Correlation Coefficient

Advanced Biomedical  Arch Biopartners

Weak diversification

The 3 months correlation between Advanced and Arch is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Advanced Biomedical Technologi and Arch Biopartners in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arch Biopartners and Advanced Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Advanced Biomedical Technologies are associated (or correlated) with Arch Biopartners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arch Biopartners has no effect on the direction of Advanced Biomedical i.e., Advanced Biomedical and Arch Biopartners go up and down completely randomly.

Pair Corralation between Advanced Biomedical and Arch Biopartners

Given the investment horizon of 90 days Advanced Biomedical Technologies is expected to under-perform the Arch Biopartners. In addition to that, Advanced Biomedical is 5.95 times more volatile than Arch Biopartners. It trades about -0.04 of its total potential returns per unit of risk. Arch Biopartners is currently generating about -0.02 per unit of volatility. If you would invest  126.00  in Arch Biopartners on May 2, 2025 and sell it today you would lose (4.00) from holding Arch Biopartners or give up 3.17% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	96.83%
Values	Daily Returns

Advanced Biomedical Technologi  vs.  Arch Biopartners

Advanced Biomedical

Risk-Adjusted Performance

Very Weak

Over the last 90 days Advanced Biomedical Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in August 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Arch Biopartners

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arch Biopartners has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Arch Biopartners is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Advanced Biomedical and Arch Biopartners

The main advantage of trading using opposite Advanced Biomedical and Arch Biopartners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Advanced Biomedical position performs unexpectedly, Arch Biopartners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arch Biopartners will offset losses from the drop in Arch Biopartners' long position.

The idea behind Advanced Biomedical Technologies and Arch Biopartners pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.